PL356447A1 - Method and compositions for treating an inflammatory disease - Google Patents

Method and compositions for treating an inflammatory disease

Info

Publication number
PL356447A1
PL356447A1 PL01356447A PL35644701A PL356447A1 PL 356447 A1 PL356447 A1 PL 356447A1 PL 01356447 A PL01356447 A PL 01356447A PL 35644701 A PL35644701 A PL 35644701A PL 356447 A1 PL356447 A1 PL 356447A1
Authority
PL
Poland
Prior art keywords
compositions
treating
inflammatory disease
inflammatory
disease
Prior art date
Application number
PL01356447A
Other languages
English (en)
Polish (pl)
Inventor
Elizabeth T. Keating
James M. Kanagy
Original Assignee
Smithkline Beecham Corporation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Corporation filed Critical Smithkline Beecham Corporation
Publication of PL356447A1 publication Critical patent/PL356447A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
PL01356447A 2000-02-08 2001-02-08 Method and compositions for treating an inflammatory disease PL356447A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US18087900P 2000-02-08 2000-02-08
PCT/US2001/003972 WO2001058441A1 (en) 2000-02-08 2001-02-08 Method and compositions for treating an inflammatory disease

Publications (1)

Publication Number Publication Date
PL356447A1 true PL356447A1 (en) 2004-06-28

Family

ID=22662062

Family Applications (1)

Application Number Title Priority Date Filing Date
PL01356447A PL356447A1 (en) 2000-02-08 2001-02-08 Method and compositions for treating an inflammatory disease

Country Status (16)

Country Link
EP (1) EP1253919A4 (pt)
JP (1) JP2003522142A (pt)
KR (1) KR20020073577A (pt)
CN (1) CN1398181A (pt)
AU (1) AU7205701A (pt)
BR (1) BR0108087A (pt)
CA (1) CA2398184A1 (pt)
CZ (1) CZ20022682A3 (pt)
HK (1) HK1051319A1 (pt)
HU (1) HUP0300689A3 (pt)
IL (1) IL150963A0 (pt)
MX (1) MXPA02007688A (pt)
NO (1) NO20023737L (pt)
PL (1) PL356447A1 (pt)
WO (1) WO2001058441A1 (pt)
ZA (1) ZA200206252B (pt)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7338971B2 (en) * 2001-08-30 2008-03-04 El-Naggar Mawaheb M Treatment of inflammatory, cancer, and thrombosis disorders
PL210463B1 (pl) * 2001-09-19 2012-01-31 Nycomed Gmbh Zastosowanie kombinacji roflumilastu z diklofenakiem w leczeniu zapalnych chorób stawów
EP1463509A1 (en) * 2001-10-31 2004-10-06 MERCK PATENT GmbH Type 4 phosphodiesterase inhibitors and uses thereof
WO2004098605A1 (en) * 2003-05-12 2004-11-18 Altana Pharma Ag Pharmaceutical composition comprising a pde4 inhibitor and il-1 trap
WO2005020926A2 (en) * 2003-08-28 2005-03-10 Pharmacia Corporation Treatment or prevention of vascular disorders with cox-2 inhibitors in combination with cyclic amp-specific phosphodiesterase inhibitors
WO2010097334A1 (de) * 2009-02-27 2010-09-02 Boehringer Ingelheim International Gmbh Arzneimittelkombinationen enthaltend pde4-inhibitoren und nsaids
EP2400961B1 (de) * 2009-02-27 2017-11-22 Boehringer Ingelheim International GmbH Arzneimittelkombinationen enthaltend pde4-inhibitoren und nsaids
EA022046B1 (ru) 2010-07-14 2015-10-30 Новартис Аг Гетероциклические соединения, агонисты рецептора ip
TW201335160A (zh) 2012-01-13 2013-09-01 Novartis Ag Ｉｐ受體激動劑之雜環化合物
ES2637719T3 (es) 2013-02-13 2017-10-16 Novartis Ag Compuestos heterocíclicos agonistas del receptor IP

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4061779A (en) * 1973-09-11 1977-12-06 Beecham Group Limited Naphthalene derivatives having anti-inflammatory activity
GB9108128D0 (en) * 1991-04-15 1991-06-05 Zambeletti Spa L Novel formulation
AU677776B2 (en) * 1992-04-02 1997-05-08 Smithkline Beecham Corporation Compounds useful for treating allergic and inflammatory diseases
US6005118A (en) * 1996-05-03 1999-12-21 Caron; Stephane Methods of preparing 4-cyano-4 (substituted indazole) cyclohexane-carboxylic acids useful as PDE4 inhibitors
FR2753706B1 (fr) * 1996-09-20 1998-10-30 Nouvelles amines cycliques n-substituees, leur procede de preparation et les compositions pharmaceutiques les renfermant

Also Published As

Publication number Publication date
HUP0300689A2 (hu) 2003-07-28
ZA200206252B (en) 2003-08-26
CA2398184A1 (en) 2001-08-16
HUP0300689A3 (en) 2003-09-29
HK1051319A1 (zh) 2003-08-01
MXPA02007688A (es) 2002-12-13
NO20023737L (no) 2002-09-27
BR0108087A (pt) 2002-10-29
KR20020073577A (ko) 2002-09-27
NO20023737D0 (no) 2002-08-07
CZ20022682A3 (cs) 2003-09-17
AU7205701A (en) 2001-08-20
EP1253919A1 (en) 2002-11-06
CN1398181A (zh) 2003-02-19
WO2001058441A1 (en) 2001-08-16
IL150963A0 (en) 2003-02-12
EP1253919A4 (en) 2007-03-14
JP2003522142A (ja) 2003-07-22

Similar Documents

Publication Publication Date Title
AP2006003708A0 (en) Methods and compositions for treating flavivirusesand pestiviruses
IL151781A0 (en) Methods and compositions for rna interference
AU2001245437A1 (en) Lightweight methods and compositions for well treating
AU2002219945A1 (en) Composition and method for treating snoring
EP1438062A4 (en) METHOD AND COMPOSITIONS FOR TREATING SKIN Lions
AU2001288271A1 (en) Methods for treating inflammatory diseases
AU6832101A (en) Composition and method
IL144517A0 (en) Compositions and methods for treating cataracts
AU5294100A (en) Method and compositions for treating the inflammatory response
AU4163402A (en) Composition and method
HUP0200224A2 (en) Compositions for treating inflammatory response
SG101494A1 (en) Exposure method
EP1443820A4 (en) COMPOSITION AND METHOD FOR TREATING REACTION OF GRAFT AGAINST HOST
EP1351647A4 (en) COMPOSITIONS AND METHODS FOR TREATING HYPERPIGMENTATION
EP1461047A4 (en) COMPOSITIONS AND METHODS FOR TREATING ANIMALS
HUP0300689A3 (en) Method and compositions for treating an inflammatory disease
EP1450820A4 (en) METHOD OF TREATING AND PREVENTING INFLAMMATORY DISEASES
IL155174A0 (en) Methods and compositions for the treatment of inflammatory diseases
IL149367A0 (en) Method and compositions for treating pulmonary diseases
AU4515001A (en) Compositions and methods for locally treating inflammatory diseases
EP1349548A4 (en) METHOD AND COMPOSITIONS FOR TREATING PERIODONTOSIS
EP1253930A4 (en) METHODS AND COMPOSITIONS FOR TREATING HEPATOCELLULAR CANCER
EP1261331A4 (en) METHOD AND COMPOSITIONS FOR TREATING FIBROSANT DISEASES
GB0123898D0 (en) Method for treating objects
GB0118883D0 (en) Method for treating objects

Legal Events

Date Code Title Description
REFS Decisions on refusal to grant patents (taken after the publication of the particulars of the applications)